GlassScriptPhysician profile
Thomas R Vidic
NPI 1265437404
$42,962.99
in general payments reported to CMS, 2019-2025
74 companies · $3,483 in 2025
The $3,483 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,551 · 2020: $13K · 2021: $12K · 2022: $5,300 · 2023: $2,963 · 2024: $3,658 · 2025: $3,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,629 · Consulting Fee: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,629.14 |
| Consulting Fee | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14,847.71 | 2019-2022 | |
| Abbvie INC. | $11,734.15 | 2021-2025 | Botox, Ubrelvy, Duopa |
| Biogen, INC. | $1,063.58 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Celgene Corporation | $795.31 | 2022-2025 | Zeposia |
| Alexion Pharmaceuticals, INC. | $788.76 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $780.26 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $724.32 | 2019-2025 | |
| Ucb, INC. | $700.34 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Genentech USA, INC. | $690.09 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Xolair |
| Eisai INC. | $669.69 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $666.50 | 2023-2025 | Fycompa |
| Novo Nordisk INC | $661.20 | 2019-2025 | Rybelsus, Ozempic |
| Neurocrine Biosciences, INC. | $553.41 | 2019-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $515.12 | 2019-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $455.47 | 2019-2025 | Mavenclad, Mavenclad |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $430.04 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Teva Pharmaceuticals USA, INC. | $405.67 | 2019-2024 | Austedo Xr, Ajovy, Austedo |
| Janssen Pharmaceuticals, INC | $378.09 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $373.86 | 2019-2025 | Amyvid, Kisunla, Reyvow |
| Sk Life Science, INC. | $346.58 | 2022-2025 | |
| Genzyme Corporation | $326.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $298.10 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Sunovion Pharmaceuticals INC. | $289.30 | 2019-2022 | |
| Amgen INC. | $284.09 | 2019-2025 | Uplizna |
| Vanda Pharmaceuticals INC. | $283.01 | 2025 | Ponvory, Fanapt |
| Banner Life Sciences, LLC | $281.71 | 2022-2024 | |
| Acadia Pharmaceuticals INC | $273.23 | 2020-2025 | Nuplazid |
| Axsome Therapeutics, INC. | $248.50 | 2023-2025 | Sunosi, Symbravo |
| Livanova USA, INC. | $225.56 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $209.68 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $192.14 | 2022-2025 | Dysport |
| Biohaven Pharmaceutical Holding Company LTD. | $181.91 | 2022 | |
| Adamas Pharmaceuticals, INC. | $170.01 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $158.96 | 2019-2025 | Crexont, Rytary, Lioresal (Baclofen) |
| Piramal Critical Care | $152.38 | 2019-2024 | |
| Avanir Pharmaceuticals, INC. | $151.75 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $108.60 | 2021-2025 | Acthar |
| Acorda Therapeutics, INC | $106.34 | 2019-2021 | |
| Tg Therapeutics, INC. | $98.97 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $97.69 | 2023-2024 | Quviviq |
| Grifols USA, LLC | $85.24 | 2019-2024 | Gamunex-C |
| Supernus Pharmaceuticals, INC. | $76.40 | 2019 | |
| Medtronic, INC. | $72.05 | 2025 | |
| Horizon Therapeutics Plc | $67.23 | 2022-2023 | Uplizna |
| Otsuka America Pharmaceutical, INC. | $66.89 | 2023-2024 | Nuedexta, Rexulti |
| Abbott Laboratories | $66.37 | 2019-2024 | Infinity |
| Kyowa Kirin, INC. | $57.29 | 2020-2022 | |
| Tanabe Pharma America, INC. | $54.76 | 2019-2025 | Radicava |
| Mdd US Operations, LLC | $54.67 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.55 | 2022-2025 | Caplyta |
| Greenwich Biosciences, INC. | $49.82 | 2019 | |
| Nevro Corp. | $43.81 | 2019 | |
| Corium, LLC | $41.43 | 2023 | Adlarity |
| Amylyx Pharmaceuticals, INC. | $41.03 | 2023 | Relyvrio |
| Cycle Pharmaceuticals INC | $38.79 | 2025 | Bafiertam, Tascenso Odt |
| Octapharma USA, INC. | $37.39 | 2023-2024 | Cutaquig, Panzyga |
| Merz Pharmaceuticals, LLC | $36.24 | 2025 | Xeomin |
| Alnylam Pharmaceuticals INC. | $34.58 | 2023 | Onpattro |
| Xeris Pharmaceuticals, INC. | $33.41 | 2022-2024 | Gvoke Hypopen |
| Life Molecular Imaging LTD | $23.66 | 2023 | Neuraceq |
| Sumitomo Pharma America, INC. | $19.79 | 2023 | Aptiom |
| Biohaven Pharmaceuticals, INC. | $18.90 | 2021 | |
| Exact Sciences Corporation | $17.11 | 2023 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $16.94 | 2019 | |
| Recordati_rare_diseases_inc. | $16.13 | 2024 | Signifor Lar, Isturisa |
| Takeda Pharmaceuticals U.S.A., INC. | $15.70 | 2023 | Takhzyro |
| Inspire Medical Systems, INC. | $15.53 | 2024 | Inspire |
| Chiesi USA, INC. | $14.70 | 2022 | |
| Amarin Pharma, INC. | $14.21 | 2020 | |
| Zyla Life Sciences, INC. | $13.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.56 | 2019 | |
| Saol Therapeutics INC. | $12.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.34 | 2020 | |
| Upsher-Smith Laboratories LLC | $11.97 | 2019 |
Drugs and devices associated with these payments
Fycompa $667Zeposia $636Tysabri $584Ultomiris $469Vyepti $418Leqembi $375Xywav $340Vumerity $323Ocrevus $317Bafiertam $281Vyvgart $277Kesimpta $269Rybelsus $253Ozempic $253Ponvory $246Botox $245Gablofen $240Verquvo $209Ingrezza $206Nurtec Odt $197Nuplazid $195Rystiggo $193Ubrelvy $189Ocrevus Zunovo $182Zavzpret $170Sunosi $169Uplizna $151Amyvid $148Dysport $139Mavenclad $134Epidiolex $124Qulipta $113Kisunla $105Briviact $104Vyvgart Hytrulo $100Briumvi $98.97Quviviq $97.69Xarelto $93.99Belsomra $77.06Acthar $73.37Austedo Xr $68.64Rexulti $55.47Steglatro $53.78Soliris $52.43Nuedexta $48.92Emgality $45.49Reyvow $45.49Crexont $44.94Vyalev $44.67Radicava $42.46Nayzilam $42.39Gardasil 9 $42.12Capvaxive $42.12Gardasil $42.12Adlarity $41.43Relyvrio $41.03Rytary $38.70Mounjaro $36.90Fanapt $36.74Xeomin $36.24Ongentys $36.19Duopa $36.11Onpattro $34.58Infinity $31.85Caplyta $31.37Zepbound $31.28Ajovy $28.68Paxlovid $27.86Aubagio $25.73Fintepla $24.45Neuraceq $23.66Plegridy $23.65Avonex $23.65Symbravo $22.18Cutaquig $21.76Lioresal (Baclofen) $21.42Gamunex-C $21.32Austedo $21.25Xolair $21.00Trulicity $20.57Aptiom $19.79Vns Therapy Sentiva Model 1000 Generator $18.31Steglujan $18.11Cologuard Collection Kit $17.11Signifor Lar $16.13Isturisa $16.13Gvoke Hypopen $16.04Takhzyro $15.70Panzyga $15.63Inspire $15.53Tascenso Odt $14.61Brekiya $14.27Mayzent $13.58
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Vidic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.